HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Tessema Selected Research

Neoplasm Metastasis (Metastasis)

9/2012SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15.
9/2010Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Tessema Research Topics

Disease

3Lung Neoplasms (Lung Cancer)
10/2013 - 09/2010
2Neoplasms (Cancer)
09/2012 - 09/2010
2Neoplasm Metastasis (Metastasis)
09/2012 - 09/2010
2Adenocarcinoma of Lung
09/2012 - 09/2010
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2012

Drug/Important Bio-Agent (IBA)

1ChromatinIBA
10/2013
1Azacitidine (5 Azacytidine)FDA Link
10/2013
1Heparitin Sulfate (Heparan Sulfate)IBA
09/2012
1Topoisomerase I InhibitorsIBA
09/2012
19 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
09/2012
1CytosineIBA
09/2012
1Pharmaceutical PreparationsIBA
09/2012
1Topotecan (Hycamtin)FDA LinkGeneric
09/2012
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
09/2012
1Biomarkers (Surrogate Marker)IBA
09/2010
1ChemokinesIBA
09/2010
1DecitabineFDA Link
09/2010
1CXC ChemokinesIBA
09/2010

Therapy/Procedure

1Drug Therapy (Chemotherapy)
09/2012
1Therapeutics
09/2012
1Aftercare (After-Treatment)
09/2010